Ayala Pharmaceuticals Inc AYLA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:09 PM EST
16.25quote price arrow down-0.73 (-4.30%)
Volume
6,345
52 week range
8.62 - 28.68

...

Loading . . .

KEY STATS

  • Open16.93
  • Day High16.96
  • Day Low16.06
  • Prev Close16.98
  • 52 Week High28.68
  • 52 Week High Date02/11/21
  • 52 Week Low8.62
  • 52 Week Low Date09/08/20
  • Market Cap207.67M
  • Shares Out12.78M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.42
  • P/E (TTM)-6.71
  • Fwd P/E (NTM)-6.56
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Ayala Pharmaceuticals Inc News

There is no recent news for this security.

Latest AYLA News From Our Partners

QUOTE FINDER

Profile

MORE
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company. It is focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. The Company’s portfolio of product candidates include AL101 and AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors. The Company’s lead product candidate, AL101, is being developed...
Address
1313 N Market St Ste 5100
Wilmington, DE
19801-6111
United States